Table 1.

Pretreatment characteristics at time of study entry for 473 patients enrolled in CALGB study 9222


Characteristic

No. patients (%)
Age, y  
   17-29   94 (20)  
   30-39   107 (23)  
   40-49   130 (27)  
   50-59   142 (30)  
Sex  
   Male   246 (52)  
   Female   227 (48)  
Race  
   White   366 (77)  
   Black   54 (11)  
   Other   53 (11)  
Performance status*  
   0   135 (29)  
   1   217 (47)  
   2   89 (19)  
   3   20 (4)  
   4
 
4 (< 1)
 

Characteristic

No. patients (%)
Age, y  
   17-29   94 (20)  
   30-39   107 (23)  
   40-49   130 (27)  
   50-59   142 (30)  
Sex  
   Male   246 (52)  
   Female   227 (48)  
Race  
   White   366 (77)  
   Black   54 (11)  
   Other   53 (11)  
Performance status*  
   0   135 (29)  
   1   217 (47)  
   2   89 (19)  
   3   20 (4)  
   4
 
4 (< 1)
 
*

n = 465